Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesion Study of ZTlido 1.8% vs Generic Lidocaine 5% in Healthy Adults
NCT04319926Phase 1Completed
- Sponsor
- Scilex Holding
- Start
- Sep 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lidocaine topical system in postherpetic neuralgia (PHN) (2 arms), sponsored by Scilex Holding. Primary endpoint: Mean Percent Adhesion. Started Sep 2018; status: completed.
02
Drugs
lidocaine topical system
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT04319926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319926.